November 17, 2025 Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring
August 21, 2025 Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit
July 28, 2025 Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer’s Research at AAIC